DiffusionInc_white background.jpg
Diffusion Pharmaceuticals Completes Enrollment and Dosing in TCOM Study
March 25, 2021 09:01 ET | Diffusion Pharmaceuticals Inc.
CHARLOTTESVILLE, Va., March 25, 2021 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or the “Company”), an innovative biopharmaceutical company developing novel...
DiffusionInc_white background.jpg
Diffusion Pharmaceuticals Doses First Participants in TCOM Study
March 18, 2021 07:05 ET | Diffusion Pharmaceuticals Inc.
CHARLOTTESVILLE, Va., March 18, 2021 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or the “Company”), an innovative biopharmaceutical company developing novel...
DiffusionInc_white background.jpg
Diffusion Pharmaceuticals Reports 2020 Financial Results and Provides Business Update
March 17, 2021 07:05 ET | Diffusion Pharmaceuticals Inc.
CHARLOTTESVILLE, Va., March 17, 2021 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or the “Company”), an innovative biopharmaceutical company developing novel...
DiffusionInc_white background.jpg
Diffusion Pharmaceuticals, Inc. to Present at the H.C. Wainwright Global Life Sciences Conference
March 04, 2021 16:05 ET | Diffusion Pharmaceuticals Inc.
CHARLOTTESVILLE, Va., March 04, 2021 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or the “Company”), an innovative biopharmaceutical company developing novel...
DiffusionInc_white background.jpg
Diffusion Pharmaceuticals Announces Full Exercise of Underwriter’s Option to Purchase Additional Shares of Common Stock
February 18, 2021 16:05 ET | Diffusion Pharmaceuticals Inc.
CHARLOTTESVILLE, Va., Feb. 18, 2021 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or the “Company”), an innovative biopharmaceutical company developing novel...
DiffusionInc_white background.jpg
Diffusion Pharmaceuticals Announces Closing of $30 Million Bought Deal Offering of Common Stock
February 17, 2021 16:13 ET | Diffusion Pharmaceuticals Inc.
CHARLOTTESVILLE, Va., Feb. 17, 2021 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or the “Company”), an innovative biopharmaceutical company developing novel...
DiffusionInc_white background.jpg
Diffusion Pharmaceuticals Completes Phase 1b Study of TSC in Hospitalized COVID-19 Patients
February 16, 2021 07:35 ET | Diffusion Pharmaceuticals Inc.
CHARLOTTESVILLE, Va., Feb. 16, 2021 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or the “Company”), an innovative biopharmaceutical company developing novel...
DiffusionInc_white background.jpg
Diffusion Pharmaceuticals Increases Previously Announced Bought Deal Offering of Common Stock to $30 Million
February 11, 2021 22:02 ET | Diffusion Pharmaceuticals Inc.
CHARLOTTESVILLE, Va., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or the “Company”), an innovative clinical stage biopharmaceutical company...
DiffusionInc_white background.jpg
Diffusion Pharmaceuticals Announces $10 Million Bought Deal Offering of Common Stock
February 11, 2021 17:54 ET | Diffusion Pharmaceuticals Inc.
CHARLOTTESVILLE, Va., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or the “Company”), an innovative clinical stage biopharmaceutical company...
DiffusionInc_white background.jpg
Diffusion Pharmaceuticals to Participate in H.C. Wainwright BioConnect 2021 Conference
January 11, 2021 07:30 ET | Diffusion Pharmaceuticals Inc.
CHARLOTTESVILLE, Va., Jan. 11, 2021 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (Nasdaq: DFFN) (“Diffusion” or “the Company”), today announced that the Company is participating in the...